A former French senator faces trial in Paris accused of drugging centrist MP Sandrine Josso with MDMA, in a case that has rocked French political circles.
Joël Guerriau, 68, formerly representing Loire-Atlantique in the Senate, is charged with administering a substance intended to impair Josso’s judgment for sexual assault. Josso reported severe heart palpitations, nausea, and difficulty standing, but escaped from Guerriau’s apartment.
Guerriau, who resigned from the Senate in October 2025, denies intending sexual assault and claims the drink was served accidentally. He faces additional charges for drug possession, which carries a potential 10-year prison sentence.
The case has spotlighted growing concerns over drug-facilitated sexual assault, particularly involving powerful figures in politics, and Josso has emerged as a leading voice advocating for stricter protections for victims.
Josso, a 50-year-old MoDem party member, has been active in parliamentary investigations into drug-related sexual crimes. She co-authored a report on drug-facilitated abuse and participates in awareness campaigns against such offenses.
According to court testimony, Josso had considered Guerriau a friend and attended what she thought would be a celebratory gathering for his re-election to the Senate.
“I expected others to be there, but he was alone when I arrived,” she said.
Josso recounted how Guerriau repeatedly encouraged her to drink more champagne.
“I felt the champagne had a distinct taste, but I was a bit tired after the working day. He said to me: ‘You’re barely drinking,’ which was irritating because I didn’t see why he’d make me drink,” she testified.
She noticed a sachet beside the glasses when Guerriau went into the kitchen. “I had extreme palpitations and nausea. I felt I might have a cardiac arrest,” Josso said, explaining how she summoned the last of her strength to leave the apartment.
Josso managed to order a taxi to the National Assembly using an app and was assisted by the driver and parliamentary colleagues who called paramedics. She later contacted Yaël Braun-Pivet, leader of the lower house, who helped her file a police complaint.
The court will examine Guerriau’s internet searches prior to the alleged incident, which could provide insights into his intent. Prosecutors argue that these searches are crucial in determining whether the act was premeditated.
Drugging a person to commit sexual assault is punishable by up to five years in prison under French law. Guerriau also faces up to 10 years for possession of illegal substances.
Josso has since become an influential figure in France’s fight against drug-facilitated sexual crimes, supporting initiatives led by activists like Caroline Darian, daughter of Gisèle Pelicot, who famously waived her anonymity in 2024 to prosecute multiple offenders after being drugged and assaulted.
The trial has prompted renewed debate in France over the safety of women in political and social environments, with many calling for stricter penalties and clearer reporting mechanisms for drug-facilitated sexual abuse.
Legal experts say the case highlights the challenges in proving intent in drugging incidents, noting that forensic evidence and witness testimony will be critical to the prosecution’s case.
Guerriau’s defense claims there was no criminal intent, emphasizing that he had no history of sexual misconduct and that the incident was a tragic misunderstanding. However, the court will weigh this against the severity of the allegations and the victim’s testimony.
Josso has urged lawmakers to improve protections for victims and increase public awareness of the risks associated with accepting drinks in private settings, especially when alone with someone known but not fully trusted.
Parliamentary discussions following the incident have focused on implementing stronger measures to prevent drug-facilitated sexual assault in political, professional, and social contexts, ensuring that victims have immediate support.
Read also: US-Iraq tensions rise as Secretary of State Rubio urges Baghdad to maintain distance from Iran
The case continues to draw media attention in France and across Europe, as observers track the proceedings and their potential impact on political accountability and safety reforms.
Both the victim and the accused are expected to testify during the trial, which may last several weeks. Evidence including digital communications, witness statements, and forensic tests will be examined.
Human rights and women’s advocacy organizations have voiced support for Josso, citing the case as emblematic of wider issues surrounding drug-facilitated abuse and the necessity of maintaining vigilance against such crimes.
The outcome of the trial could set a legal precedent in France regarding how drugging incidents with sexual intent are prosecuted, potentially influencing laws in neighboring countries.
Meanwhile, Josso continues her advocacy work, emphasizing education, awareness, and policy reform as key tools in the fight against sexual crimes involving drugs.
Observers say the case may encourage other victims to come forward, highlighting the importance of robust reporting systems and strong legal consequences for offenders.
Guerriau remains free pending trial but is prohibited from contacting the victim. His defense team insists on his cooperation and willingness to clarify the events in court.
The trial underscores ongoing concerns about abuse of power and trust in political settings, reinforcing calls for transparency, accountability, and stricter legal measures.
France’s political class watches closely, as the case has implications not only for the individuals involved but also for the broader culture surrounding gender, consent, and professional safety.
The legal proceedings are expected to continue over the coming weeks, with both prosecution and defense presenting evidence, expert testimony, and witness accounts before a judgment is reached.
About The Author
